AI system
- System
-
Apple Watch Series 3 heart-rate readings (optical photoplethysmography)
- Model
-
Not assessed
- Release
-
Exact release not established.
- Application developer
-
Apple - Role
-
Not assessed
- Configuration
-
The participant used an Apple Watch Series 3.
- Inputs and outputs
-
Not assessed
- Autonomy
-
Not assessed
- Workflow
-
A patient with known paroxysmal AF wearing a heart-rate-displaying smartwatch while a Holter monitor was also fitted. The patient noticing and reporting a sudden, persistent heart-rate drop with its time. Clinicians willing to export the watch readings (Apple Health app to Excel) and align them with the Holter.
- Human oversight
-
Not assessed
- Relation to AI
-
No alert, notification or rhythm classifier was involved. The watch displayed a photoplethysmographic heart-rate estimate, the patient noticed the drop, and the authors compared the readings with the Holter afterwards. The paper does not describe the heart-rate estimation as machine learning. So the AI character of the contribution is not established.
- AI contribution
-
No alert, notification or rhythm classifier was involved. The watch displayed a photoplethysmographic heart-rate estimate, the patient noticed the drop, and the authors compared the readings with the Holter afterwards. The paper does not describe the heart-rate estimation as machine learning. So the AI character of the contribution is not established.
Benefits
- Outcome identifiers
-
Not assessed
- Benefit
-
sudden 99-to-65 bpm drop at 19:29 that coincided with reversion from AF to sinus rhythm
- Category
-
Improved Physical Health
- Status
-
Not assessed
- Beneficiary groups
-
People.
- Beneficiaries
-
Not assessed
- Reach
-
Not assessed
- Distribution and access
-
Not assessed
- Duration
-
Not assessed
- Expected?
-
Yes
- Costs and harms
-
Not assessed
Measurement
- Studies
-
Not assessed
- Study design
-
Not assessed
- Measurement
-
Not assessed
- Setting and sample
-
Not assessed
- Measures
-
sudden 99-to-65 bpm drop at 19:29 that coincided with reversion from AF to sinus rhythm
- Comparison
-
a concurrent 24-hour Holter monitor
- Results
-
sudden 99-to-65 bpm drop at 19:29 that coincided with reversion from AF to sinus rhythm
- Additional value from AI
-
Not assessed
- Limitations
-
Not assessed
- Denominators
-
Not assessed
- Materials for replication
-
Not assessed
Money
- Kind of value
-
Not assessed
- Amount
-
Not assessed
- Currency and prices
-
Not assessed
- Period and unit
-
Not assessed
- Realization
-
Not assessed
- Recipients and payers
-
Not assessed
- Gross or net
-
Not assessed
- Included costs
-
Not assessed
- Comparison
-
Not assessed
- Method
-
Not assessed
- Return and payback
-
Not assessed
People and places
- Participants
-
Developer:
Apple. - Jurisdictions
-
Benefit: Melbourne,
Australia. Developer:
United States. - Ownership and control
-
Not assessed
- Dependencies
-
Not assessed
- Cross-border connections
-
Not assessed
- Geopolitical implications
-
Not assessed
Follow-up
- Conditions for replication
-
The rhythm change produces a heart-rate change large enough to be visible on the watch's optical estimate. A reference recording (Holter) exists to confirm what the watch suggested.
- Replication attempts
-
Not assessed
- Later findings
-
The report says only that outcomes of smartwatch-detected arrhythmias are the subject of ongoing research; nothing later was found.
- Availability
-
Not assessed
- Institutional decision
-
Not assessed
- Grounds
-
Not assessed
- Action and result
-
Not assessed
- Success criterion
-
Not assessed
Evidence
- Source numbers
-
AIBD-0284-source-0001–0003
- Citations
-
Numbered references below.
- Language
-
Not assessed
- Source relationships
-
Independent
- Original evidence
-
Not assessed
- Access and versions
-
Not assessed
- Supported findings
-
Not assessed
- Evidence links
-
Not assessed
- Evidence strength
-
Not assessed
- Missing evidence
-
Not assessed
Grades
- Assessed benefits
-
People.
- Depth
-
People: 1.
- Reasons
-
People: The patient learned from her watch, and had confirmed by Holter, that her rhythm had reverted at 19:29. The report records no change in management, so the benefit is informational only.
- Observed or intended
-
Not assessed
- Rubric
-
Not assessed
- Assessor and date
-
Not assessed
- Alternative assessments
-
Not assessed
- Fill
-
Independently studied
Entry details
- Kind
-
Not assessed
- Related entries
-
Not assessed
- Field
-
Healthcare (cardiology). Consumer wearables.
- Purpose
-
The watch's optical heart-rate estimate is built to show the wearer their pulse. Its use here to time a rhythm change was that function, read by the patient rather than flagged by the device.
- Dates
-
Date basis unassessed: 2020 (precision unassessed). Updated: 21 October 2026.
- Stage
-
Not assessed
- Version
-
SHA-256: 21ad16cb86c2…
References
- Other identifiers
-
Not assessed
- Category mappings
-
Not assessed
- Brief
-
Not assessed
- Revisions
-
5 revisions. Latest: 21 October 2026.
Sources
-
Case report Independent author
Toner L, Al-Kaisey AM, Koshy A, Lim HS (2020). Spontaneous reversion of paroxysmal atrial fibrillation detected by smart watch. BMJ Case Reports 13(2):e233431. doi:10.1136/bcr-2019-233431 (PMC7035811).
she noted her heart rate suddenly drop from 99 bpm to 65 bpm as measured by her Apple Watch Series 3 (Cupertino, USA)
Sudden and persistent changes in heart rate as detected by smart watches should alert clinicians to the possibility of cardiac rhythm changes.
-
Case report Independent author
Toner L et al. (2020), BMJ Case Reports 13(2):e233431, Holter confirmation.
Review of the Holter monitor revealed she had reverted from AF to SR at that time
Collections: Cross-border cases.